The inhibition of inducible nitric oxide synthase reverts arthritic-induced decrease in pituitary growth hormone mRNA but not in liver insulin-like growth factor I mRNA expression

Journal of Neuroendocrinology

Volumn 15, Issue 12, 2003, Pages 1178-1184

  Ibanez de Caceres I ^a   Priego, T ^a   Martin A I ^b   Lopez Calderon A ^a   Villanua M A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD EUROPEA DE MADRID   (Spain)

Author keywords

Aminoguanidine; Arthritis; GH; IGF I; Somatostatin

Indexed keywords

AMINOGUANIDINE; FREUND ADJUVANT; GROWTH HORMONE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SOMATOMEDIN C; SOMATOSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CELL LEVEL; CONTROLLED STUDY; DECAPITATION; ENZYME INHIBITION; GENE EXPRESSION; GROWTH HORMONE BLOOD LEVEL; HORMONE RELEASE; HYPOPHYSIS; HYPOPHYSIS CELL; HYPOTHALAMUS; LIVER; LIVER CELL; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CHRONIC DISEASE; ENZYME INHIBITORS; GENE EXPRESSION; GROWTH HORMONE; GUANIDINES; INSULIN-LIKE GROWTH FACTOR I; LIVER; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PITUITARY GLAND; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 0347382585     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2003.01117.x     Document Type: Article

References (54)

1. Roubenoff R, Roubenoff RA, Cannon JG, Kehayias JJ, Zhuang H, Dawson-Hughes B, Dinarello CA, Rosenberg IH. Rheumatoid cachexia: cytokine-driven hypermetabolism and loss of lean body mass in chronic inflammation. J Clin Invest 1994; 93: 2379-2386.
2. Harbuz MS, Lightman SL. Stress and hypothalamic-pituitary-adrenal axis: acute, chronic and immunological activation. J Endocrinol 1992; 134: 327-339.
3. Ibáñez de Cáceres I, Villanúa MA, Soto L, Martín AI, López-Calderón A. IGF-I and IGF-I-binding proteins in rats with adjuvant-induced arthritis given recombinant human growth hormone. J Endocrinol 2000; 165: 537-544.
4. Neidhart M, Flückiger EW. Hyperprolactinemia in hypophysectomized or intact male rats and the development of adjuvant arthritis. Immunology 1992; 77: 449-455.
5. Stephanou A, Sarlis NJ, Knight RA, Lightman SL, Chowdrey HS. Glucocorticoid-mediated responses of plasma ACTH and anterior pituitary pro-opiomelanocortin, growth hormone and prolactin mRNAs during adjuvant-induced arthritis in the rat. J Mol Endocrinol 1992; 9: 273-281.
6. López-Calderón A, Soto L, Martín AI. Chronic inflammation inhibits GH secretion and alters the serum insulin-like growth factor system in rats. Life Sci 1999; 65: 2049-2060.
7. López-Calderón A, Ibáñez de Cáceres I, Soto L, Priego T, Martín AI, Villanúa MA. The decrease in hepatic IGF-I gene expression in arthritic rats is not associated with modifications in hepatic GH receptor mRNA. Eur J Endocrinol 2001; 144: 1-6.
8. Cannon GW, Openshaw SJ, Hibbs JB, Hoidal JR, Huecksteadt TP. Griffiths MM. Nitric oxide production during adjuant-induced and collagen-induced arthritis. Arthritis Rheum 1996; 39: 1677-1684.
9. Wu J, Ling Q, Lu Y, Willis WD, Westlund KN. Changes in nitric oxide synthase isoforms in the spinal cord of rat following induction of chronic arthritis. Exp Brain Res 1998; 118: 457-465.
10. Nathan C. Perspectives series: nitric oxide and nitric oxide synthases. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997; 100: 2417-2423.
11. Connor JR, Manning PT, Settle SL, Moore WM, Jerome GM, Webber RK. Tjoeng FS, Currie MG. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur J Pharmacol 1995; 273: 15-24.
12. Tanaka S, Matsui T, Murakami T, Ishizuka T, Sugiura M, Kawashima K, Sugita T. Immunological abnormality associated with the augmented nitric oxide synthesis in adjuvant-induced arthritis. Int J Immunopharmacol 1998; 20: 71-84.
13. Bonavera J, Sahu A, Kalra P, Kalra S. Evidence that nitric oxide may mediate the ovarian steroid-steroid-induced luteinizing hormone surge: involvement of excitatory amino acids. Endocrinology 1993; 133: 2481-2487.
14. Volpi R, Chiodera P, Caffarri G, Vescovi P, Capretti L, Gatti C, Coiro V. Influence of nitric oxide on hypoglycemia- or angiotensin II-stimulated ACTH and GH secretion in normal men. Neuropeptides 1996; 30: 528-532.
15. Prevot V, Bouret S, Stefano GB, Beauvillain JC. Median eminence nitric oxide signaling. Brain Res Rev 2000; 34: 27-41.
16. Rettori V, Belova N, Yu WH, Gimeno M, McCann SM. Role of nitric oxide in control of growth hormone release in the rat. Neuroimmunomodulation 1994; 1: 195-200.
17. Fisker S, Nielsen S, Ebdrup L, Bech JN, Christiansen JS, Pedersen EB, Jørgense JOL. The role of nitric oxide in L-arginine-stimulated growth hormone release. J Endocrinol Invest 1999; 22: 89-93.
18. Pinilla L, Tena-Sempere M, Aguilar E. Nitric oxide stimulates growth hormone secretion in vitro through a calcium- and cyclic guanosine monophosphate-independent mechanism. Horm Res 1999; 51: 242-247.
19. Vankelecom H, Matthys P, Denef C. Involvement of nitric oxide in the interferon-gamma-induced inhibition of growth hormone and prolactin secretion in anterior pituitary cell cultures. Mol Cell Endocrinol 1997; 129: 157-167.
20. 3 cells. Endocr J 1999; 46: 779-785.
21. Tanaka H, Ueta Y, Yamashita U, Kannan M, Yamashita H. Biphasic changes in behavioural, endocrine and sympathetic systems in adjuvant arthritis in Lewis rats. Brain Res Bull 1996; 39: 33-37.
22. 15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
23. Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001; 5: 62-71.
24. Soto L, Martín AI, Millán S, Vara E, López-Calderón A. Effects of endotoxin lipopolysaccharide administration on the somatotropic axis. J Endocrinol 1998; 159: 239-246.
25. Torres-Alemán I, Pons S, Santos-Benito FF. Survival of purkinje cells in cerebellar cultures is increased by insulin-growth factor I. Eur J Neurosci 1992; 4: 864-869.
26. Roberts CT, Lasky SR, Lowe WL, Seaman WT, LeRoith D. Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues. Mol Endocrinol 1987; 1: 243-248.
27. Baumbach WR, Horner DL, Logan JS. The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor. Genes Dev 1989; 3: 1199-1205.
28. Goodman RH, Aron DC, Roos BA. Rat pre-prosomatostatin structure and processing by microsomal membranes. J Biol Chem 1983; 258: 5570-5573.
29. Peter HS, Shine J, Martial JA, Baxter JD, Goodman HM. Nucleotide sequence and amplification in bacteria of structural gene for rat growth hormone. Nature 1977; 270: 486-494.
30. Bluet-Pajot MT, Mounier F, Slama A, Videau C, Kordon C, Epelbaum J, Calvino B. The increase in growth hormone secretion in experimentally induced arthritic rats is an adaptive process involved in the regulation of inflammation. Neuroendocrinology 1996; 63: 85-92.
31. Alba-Roth J, Muller OA, Schoopohl J, von Werder K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J Clin Endocrinol Metab 1988; 67: 1186-1189.
32. Ghigo E, Bellone J, Mazza E, Imperiale E, Procopio M, Valente F, Lalla R, De Sanctis C, Camanni F. Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children: further evidence for a somatostatin suppressing effect of arginine. Clin Endocrinol 1996; 32: 763-767.
33. Aguila MC. Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase. Proc Natl Acad Sci USA 1994; 91: 782-786.
34. Bhat G, Mahesh VB, Aguan K, Brann DW. Evidence that brain nitric oxide synthase is the major nitric oxide synthase isoform in the hypothalamus of the adult female rat and that nitric oxide potently regulates hypothalamic cGMP levels. Neuroendocrinology 1996; 64: 93-102.
35. Mohn C, Lomniczi A, Faletti A, Scorticati C, Elverdin JC, McCann SM, Rettori V. Effects of aminoguanidine and meloxicam on nitric oxide and prostaglandin E production induced by lipopolysaccharide in the hypothalamus and anterior pituitary of the rat. Neuroimmunomodulation 2001; 9: 276-285.
36. Peisen JN, McDonnell KJ, Mulroney SE, Lumpkin MD. Endotoxin-induced suppression of the somatotropic axis is mediated by interleukin-1 beta and corticotropin-releasing factor in the juvenile rat. Endocrinology 1995; 136: 3378-3390.
37. Honegger J, Spagnoli A, D'Urso R, Navarra P, Tsagarakis S, Besser GM, Grossman AB. Interleukin-1 beta modulates the acute release of growth hormone-releasing hormone and somatostatin from rat hypothalamus in vitro, whereas tumor necrosis factor and interleukin-6 have no effect. Endocrinology 1991; 129: 1275-1282.
38. Cash D, Beech JS, Rayne RC, Bath PM, Meldrum BS, Williams SC. Neuroprotective effect of aminoguanidine on transient focal ischaemia in the rat brain. Brain Res 2001; 905: 91-103.
39. Lu J, Moochhala S, Shirhan M, Chye Ng K, Ling Teo A, Hong Tan M, Lei Moore X, Cheong Wong M, Ang Ling E. Neuroprotection by aminoguanidine after lateral fluid-percussive brain injury in rats: a combined magnetic resonance imaging, histopathologic and functional study. Neuropharmacology 2003; 44: 253-263.
40. Olivenza R, Moro MA, Lizasoain I, Lorenzo P, Fernandez AP, Rodrigo J, Bosca L, Leza JC. Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex. J Neurochem 2000; 74: 785-791.
41. Wakita T, Shintani F, Yagi G, Asai M, Nozawa S. Comibination of inflammatory cytokines increases nitrite and nitrate levels in the paraventricular nucleus of conscious rat. Brain Res 2001; 905: 12-20.
42. LaPaglia N, Steiner J, Kirsteins L, Emanuele M, Emanuele N. Leptin alters the response of the growth hormone releasing factor-growth hormone-insulin-like growth factor-I axis to fasting. J Endocrinol 1998; 159: 79-83.
43. Lam KSL, Lee MF, Tam SP, Srivastava G. Gene expression of the receptor for growth-hormone-releasing hormone is physiologically regulated by glucocorticoids and estrogen. Neuroendocrinology 1996; 63: 475-480.
44. Qian X, Jin L, Lloyd RV. Percoll density gradient-enriched populations of rat pituitary cells: Interleukin 6 secretion, proliferative activity, and nitric oxide synthase expression. Endocr Pathol 1998; 9: 339-346.
45. Kostic TS, Andric SA, Stojilkovic SS. Spontaneous and receptor-controlled soluble guanylyl cyclase activity in anterior pituitary cells. Mol Endocrinol 2001; 15: 1010-1022.
46. Rigamonti AE, Cella SG, Cavallera GM, Deghenghi R, Locatelli V, Pitsikas N, Müller EE. Contrasting effects of nitric oxide on food intake and GH secretion stimulated by a GH-releasing peptide. Eur J Endocrinol 2001; 144: 155-162.
47. Kato M. Involvement of nitric oxide in growth hormone (GH)-releasing hormone-induced GH secretion in rat pituitary cells. Endocrinology 1992; 131: 2133-2138.
48. Valverde I, Peñalva A, Ghigo E, Casanueva FF, Dieguez C. Involvement of nitric oxide in the regulation of growth hormone secretion in dogs. Neuroendocrinology 2001; 74: 213-219.
49. Tena-Sempere M, Pinilla L, González D, Aguilar E. Involvement of endogenous nitric oxide in the control of pituitary responsiveness to different elicitors of growth hormone release in prepubertal rats. Neuroendocrinology 1996; 64: 146-152.
50. Uretsky AD, Chang JP. Evidence that nitric oxide is involved in the regulation of growth hormone secretion in goldfish. General Comp Endocrinol 2000; 118: 461-470.
51. Bocca L, Valenti S, Cuttica CM, Spaziante R, Giordano G, Giusti M. Nitric oxide biphasically modulates GH secretion in cultured cells of GH-secreting human pituitary adenomas. Minerva Endocrinol 2000; 25: 55-59.
52. Zamora R, Vodovotz Y, Aulak KS, Kim PK, Kane JM, Alarcon L, Stuehr DJ, Billiar TR. A DNA microarray study of nitric oxide-induced genes in mouse hepatocytes: implications for hepatic heme oxygenase-1 expression in ischemia/repefusion. Nitric Oxide 2002; 7: 165-186.
53. Zhang GL, Wang YH, Teng HI, Lin ZB. Effects of aminoguanidine on nitric oxide production induced by inflammatory cytokines and endotoxin in cultures rat hepatocytes. World J Gastroenterol 2001; 7: 331-334.
54. Priego T, Ibáñez de Cáceres I, Martín AI, Villanúa MA, López-Calderón A. Nitric oxide plays a role in endotoxin-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver. Am J Physiol Endocrinol Metab, in